Home › Products › Oncology › Dacoplice 15mg Tablet
Dacoplice 15mg Tablet
Salt Composition: DACOMITINIB
- Manufacturer: PFIZER LTD
- Pack Size: 30 TABLET(s) IN A BOTTLE
- Dosage Form: TABLET
- Strength: 15MG
- Prescription Required
- Storage: Store Dacoplice 15mg Tablet at room temperature ( 20 °C to 25 °C) keep the injection away from the reach of children and pets. If you forgot to take a dose, take it as soon as you remember. however, skip the missed dose if it is nearly time for the next dose. Do not take a double dose to make up a forgotten dose. Avoid direct contact with crushed tablets with the skin or mucous membrane. If such contact occurs, wash thoroughly.
₹34169.00₹43804.69
Inclusive of all taxes
Product Introduction
Dacoplice 15mg Tablet is an anticancer medication containing Dacomitinib, a tyrosine kinase inhibitor. It is indicated for first-line treatment of non-small cell lung cancer (NSCLC) that has spread to other parts of the body and has specific EGFR gene mutations. This tablet works by blocking signals that promote the growth of cancer cells. Before starting Dacoplice 15mg, inform your doctor if you have any lung, liver, kidney, or heart conditions, as the medicine may worsen certain pre-existing problems. Do not take Dacoplice if you are allergic to Dacomitinib or any of its ingredients. If you experience diarrhoea, skin rash, or signs of jaundice (such as yellowing of skin or eyes, dark urine, or pale stools), seek medical attention immediately. It is not recommended for children under 18 years, or for use during pregnancy or breastfeeding. Dacoplice 15mg side effects include skin rash, nail changes, sore mouth, loss of appetite, dry skin, hair loss, weight loss, and itching. Your doctor will guide you on how to take Dacoplice tablet and may adjust the Dacoplice 15mg tablet dosage based on your response and tolerability of side effects.
Uses
Metastatic non-small cell lung cancer with positive EGFR
How it works
Dacomitinib is a protein-tyrosine kinase inhibitor that blocks a specific abnormal protein created by a chromosomal abnormality that signals cancer cells to multiply. It inhibits the multiplication and induces cell death in abnormal cancer cells.
How to Use
Your doctor will decide the dose and duration of the treatment based on your disease condition, severity, and other factors. Take the tablets as prescribed by your doctor. Do not break, crush, or chew the tablets. Swallow the tablet whole with a glass of water. Take this medicine with a meal to avoid stomach problems. Take the tablet at about the same time each day.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Dacoplice 15â¯mg tablet side effects include Common Hair fall Inflammation in the nails Itchy skin Dry skin Decreased weight Decreased appetite Inflamed and sore mouth cough Serious Severe itchy skin Diarrhea Respiratory illness
Expert Tips
This medicine contains lactose; if you're intolerant to certain sugars, consult your doctor before use. Your doctor will perform regular lab tests to monitor the effectiveness of the treatment. Do not breastfeed during treatment and for 17 days after the last dose. The medicine may cause increased sensitivity to sunlight. Use sunscreen (only after medical advice) and wear protective clothing when outdoors.
References
- HIGHLIGHTS OF PRESCRIBING INFORMATION. [Revised on 2018] [cited 2023 Mar 23]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/211288s000lbl.pdf
- Vizimpro 45 mg film-coated tablets - Summary of Product Characteristics (SmPC) - (emc). www.medicines.org.uk. [Revised on 2021] [cited 2023 Mar 23]. Available from: https://www.medicines.org.uk/emc/product/10356/smpc
- Sally CM Lau et al; Dacomitinib in the Management of Advanced Non-Small-Cell Lung Cancer; Drugs; Published on June 2019; Accessed on 02/12/2021; https://pubmed.ncbi.nlm.nih.gov/31069718/
Safety Advice
Pregnancy: unsafe Dacoplice 15mg Tablet is unsafe to administer in pregnant women because it may affect the fetus. Inform your physician if you are pregnant, suspect pregnancy, or planning to become pregnant. An effective birth control method is necessary during the treatment and for 17 days after your last dose.
Lungs: Consult your doctor It is unknown whether Dacoplice 15mg Tablet can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.
Breastfeeding: unsafe Breastfeeding is not recommended in patients taking Dacoplice 15mg Tablet because the medicine passes into the breast milk in small amounts and may harm your baby.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.